Australia · Delayed Price · Currency is AUD Solvar Earnings Call Transcripts
Fiscal Year 2026
-
FY 2026 saw normalized NPAT rise to AUD 36.1 million and strong loan book growth in Australia, offsetting the wind-down in New Zealand. The group expects double-digit revenue growth in FY 2027, supported by robust funding, tech investment, and improved portfolio quality.
-
Bennji commercial lending division is growing rapidly, with the loan book expected to double by March. Normalized net profit after tax reached AUD 20 million, aided by the NZ asset sale, and full-year guidance is reaffirmed at AUD 36 million. Regulatory issues are largely resolved, and dividend payouts remain strong.
Fiscal Year 2025
-
The meeting highlighted modest growth in loan book and revenue, a strong dividend increase, and strategic investments in technology and new business lines. Board changes, robust governance, and ongoing regulatory matters were discussed, with shareholders engaging on dividends and capital management.
-
FY 2025 saw 5% loan book growth, a 70% increase in net profit after tax, and a 40% dividend uplift, driven by disciplined lending, cost reductions, and strategic investments. Bennji's commercial lending launch and strong funding headroom position the group for robust growth in FY 2026.
-
Normalized NPAT rose 27% to AUD 18.5 million and revenue grew 4.6% year-over-year, driven by strong AFS performance and cost management. Technology upgrades, funding diversification, and a new commercial lending unit position the group for double-digit loan book growth in FY2026. Regulatory and election uncertainties remain.
Fiscal Year 2024
-
The meeting reviewed strong loan book and revenue growth, ongoing dividends, and strategic refocus on Australian commercial lending. Board changes, technology investments, and compliance enhancements were highlighted, while legal and regulatory risks remain key challenges.
-
Revenue and loan book growth in Australia offset New Zealand contraction, with normalized profit at AUD 29 million. Strong cash position and new funding support continued expansion, while regulatory and macroeconomic risks are being managed.